Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS

Bioanalysis

Volumn 5, Issue 18, 2013, Pages 2257-2268

  Øiestad, Elisabeth L ^a   Johansen, Unni ^a   Christophersen, Asbjørg S ^a   Karinen, Ritva ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; AM 2201; AM 694; CANNABINOID; DEXANABINOL; JWH 019; JWH 020; JWH 073; JWH 081; JWH 122; JWH 200; JWH 210; JWH 250; JWH 251; RCS 4; RCS 4 C4; RCS 8; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG; WIN 55 212 2; DESIGNER DRUG; STREET DRUG;

ACCURACY; ANALYTICAL EQUIPMENT; ANALYTICAL PARAMETERS; ARTICLE; BODY FLUID; CALIBRATION; CAR DRIVING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRIVING UNDER THE INFLUENCE OF DRUG; DRUG ABUSE; FALSE POSITIVE RESULT; HUMAN; ION PAIR CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; ORAL FLUID; PRISONER; RETENTION TIME; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION; SYSTEMATIC ERROR; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES; REPRODUCIBILITY; SALIVA; SUBSTANCE ABUSE; SYNTHESIS;

CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; HUMANS; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84884993905     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.182     Document Type: Article

References (36)

1. EMCDDA. 2012 Annual Report on the State of the Drugs Problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal (2012).
2. SIRUS Norwegian Institute for Alcohol and Drug Research. The Drug Situation in Norway 2012. Annual Report to the European Monitoring Centre for Drugs and Drug Addiction. EMCDDA, 1-87 (2013).
3. Ammann J, McLaren JM, Gerostamoulos D et al. Detection and quantification of new designer drugs in human blood: part 1 synthetic cannabinoids. J. Anal. Toxicol. 36(6), 372-380 (2012).
4. Dresen S, Kneisel S, Weinmann W et al. Development and validation of aliquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 46(2), 163-171 (2011).
5. Kacinko SL, Xu AL, Homan JW et al. development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J. Anal. Toxicol. 35(7), 386-393 (2011).
6. Kneisel S, Auwärter V Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 47(7), 825-835 (2012).
7. Shanks KG, Dahn T, Terrell AR. Detection of JWH-018 and JWH-073 by UPLC-MS/MS in postmortem whole blood casework. J. Anal. Toxicol. 36(3), 145-153 (2012).
8. Beuck S, Moller I, Thomas A et al. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal. Bioanal. Chem. 401(2), 493-505 (2011).
9. de Jager AD, Warner JV, Henman M et al. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine - an Australian perspective. J. Chromatogr. B 897, 22-31 (2012).
10. Elsohly MA, Gul W, Elsohly KM et al. Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J. Anal. Toxicol. 35(7), 487-496 (2011).
11. Grigoryev A, Savchuk S, Melnik A et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B 879(15/16), 1126-1136 (2011).
12. Hutter M, Broecker S, Kneisel S et al. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in herbal mixtures' using LC-MS/MS techniques. J. Mass Spectrom. 47(1), 54-65 (2012).
13. Moller I, Wintermeyer A, Bender K et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal. 3(9), 609-620 (2011).
14. Moran CL, Le VH, Chimalakonda KC et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 83(11), 4228-4236 (2011).
15. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 200(1-3), 141-147 (2010).
16. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test Anal. 4, 745-753 (2012).
17. Strano-Rossi S, Anzillotti L, Castrignano E et al. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, 'spice' and stimulants in oral fluid. J. Chromatogr. A 1258 37-42 (2012).
18. Coulter C, Garnier M, Moore C. Synthetic cannabinoids in oral fluid. J. Anal. Toxicol. 35(7), 424-430 (2011).
19. Kneisel S, Auwarter V, Kempf J. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. Drug Test Anal. 5, 657-669 (2013).
20. Auwärter V, Kneisel S, Hutter M et al. Synthetische cannabinoide. Rechtsmedizin 22(4), 259-271 (2012).
21. Allen KR, Azad R, Field HP et al. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42, 277-284 (2005).
22. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin. Chem. 55(11), 1910-1931 (2009).
23. Heltsley R, Depriest A, Black DL et al. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. J. Anal. Toxicol. 35(8), 529-540 (2011).
24. Moore C. Oral fluid for workplace drug testing: laboratory implementation. Drug Test Anal. 4(2), 89-93 (2012).
25. Vindenes V, Yttredal B, Oiestad EL et al. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine. J. Anal. Toxicol. 35(1), 32-39 (2011).
26. Kauert GF, Ramaekers JG, Schneider E et al. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J. Anal. Toxicol. 31(5), 288-293 (2007).
27. Øiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 53(2), 300-309 (2007).
28. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019-3030 (2003).
29. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int. 150(2-3), 165-173 (2005).
30. Gunnar T, Ariniemi K Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J. Mass Spectrom. 40(6), 739-753 (2005).
31. Kauert GF, Iwersen-Bergmann S, Toennes SW. Assay of Delta9- tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J. Anal. Toxicol. 30(4), 274-277 (2006).
32. Lee D, Milman G, Barnes AJ et al. Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin. Chem. 57(8), 1127-1136 (2011).
33. Kneisel S, Teske J, Auwärter V. Analysis of synthetic cannabinoids in abstinence control: long drug detection windows in serum and implications for practitioners. Drug Test. Anal. doi:10.1002/dta.1445 (2013) (Epub ahead of print).
34. Norwegian police drug statistics. www.politi.no/kripos/statistikk/ narkotika
35. Norwegian drug list.www.lovdata.no/for/sf/ho/to-19780630-0008-001.html
36. Intercept® oral fluid drug test collection procedure.www.orasure.com/ products-substance/products-substance-abuse-intercept.asp